VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
63,880
AK1,568
AL4,958
AR3,125
AS44
AZ12,785
CA55,187
CO10,507
CT7,403
DC1,577
DE1,570
FL33,803
FM3
GA12,582
GU74
HI2,086
IA4,141
ID2,365
IL18,289
IN22,075
KS4,075
KY6,297
LA4,427
MA13,201
MD11,343
ME2,866
MH8
MI16,818
MN10,736
MO8,401
MP30
MS2,497
MT2,039
NC14,507
ND1,186
NE2,572
NH2,727
NJ16,176
NM3,543
NV3,814
NY31,129
OH17,125
OK5,698
OR7,535
PA21,253
PR1,968
QM2
RI1,837
SC5,637
SD1,093
TN8,087
TX32,144
UT3,807
VA13,235
VI49
VT1,603
WA13,077
WI9,900
WV2,130
WY758
XB5
XL1
XV2

ID: 1482292
Sex: F
Age:
State: TN

Vax Date: 03/22/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hard swollen lump at the injection site.; Injection site itchy; Becomes red if barely rubbed; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the arm on 22Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient previously received cephalexin and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), phentermine (MANUFACTURER UNKNOWN), vitamin b nos (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and biotin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient reported that she had no symptoms until one week from the first dose and her arm was not even sore. On 30Mar2021 at 20:00, the patient reported that she had a hard swollen lump at the injection site. It was itchy and became red if she barely rubbed it. No therapeutic measures were taken for any of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events hard swollen lump at the injection site, itchy injection site and red injection site were not resolved. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: PHENTERMINE; BIOTIN; VITAMIN B NOS; VITAMIN D NOS; Vitamin c; WELLBUTRIN

Current Illness:

ID: 1482293
Sex: F
Age:
State: NY

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe gastrointestinal upset; diarrhea; fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 54-Year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 28Mar2021 at 15:00 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history included atherosclerosis, coronary artery disease, spinal stenosis, obesity, mild chronic obstructive pulmonary disease (COPD) (smoking) and penicillin allergy. Concomitant medications included ibuprofen 800 mg (MANUFACTURER UNKNOWN) and clonazepam (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 29Mar2021 at 04:00, the patient experienced severe gastrointestinal upset, diarrhea and fatigue. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events severe gastrointestinal upset, diarrhea and fatigue. The clinical outcomes of the events severe gastrointestinal upset, diarrhea and fatigue were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; CLONAZEPAM

Current Illness:

ID: 1482294
Sex: F
Age:
State: UT

Vax Date: 03/10/2021
Onset Date: 03/14/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tinnitus, very loud ringing/buzzing in ear; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the arm right on 10Mar2021 at 12:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included losartan (MANUFACTURER UNKNOWN) , prasterone (DHEA) , pregnenolone (MANUFACTURER UNKNOWN) , progesterone (MANUFACTURER UNKNOWN) and estradiol (ESTRAD). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021 at 00:00, the patient experienced tinnitus, very loud ringing/buzzing in ear. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tinnitus, very loud ringing/buzzing in ear was not resolved. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LOSARTAN; DHEA; PREGNENOLONE; PROGESTERONE; ESTRAD

Current Illness:

ID: 1482295
Sex: F
Age:
State: TN

Vax Date: 03/15/2021
Onset Date: 03/17/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The pain got worse; gout; Bunion redness; Bunion swelling; Bunion soreness; Inflamed big toe area; lots of pain; bunion; Acid reflux; This is a spontaneous report from a contactable consumer (patient reported for herself). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 15Mar2021 at 11:00 (at the age of 63-year-old) (Batch/Lot Number: EN5318; Expiration Date: 31May2021) as single for covid-19 immunisation; Pravastatin (Teva product), oral for about 2 or 3 years (Lot Number: 100015462; Expiration Date: Dec2021) and ongoing, at 20 mg for blood cholesterol abnormal. She supposed to take it every day but she was taking it maybe every other day. There were lots of numbers on the bottle. She saw the lot number, a GTIN, and STIN. She did not locate an NDC number. Medical history included ongoing diabetes mellitus It started in her 30s or early 40s, ongoing Blood pressure high, it started in her 30s, thyroid problem, arthritis in her big toes, Acid reflux and High cholesterol. Family Medical History Relevant to AE(s): Her mother did not have acid reflux and her father did not. Her brother had gout, but she was sure it was his diet. She was never had gout just the acid reflux, she takes medication for acid reflux. There were no concomitant medications. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Prior Vaccinations within 4 weeks were none. AE(s) following prior vaccinations was none. She had the flu vaccine for the first-time last year and had no symptoms. On 17Mar2021, after the vaccination, the patient developed Acid reflux. On 18Mar2021 morning, she developed gout, Bunion with redness, swelling, soreness and Inflamed big toe area with lots of pain. The clinical course of the events as follows: the patient took vaccine on 15Mar2021 (Monday) and did not have any issues until 16Mar2021 (Tuesday) and she was okay. On 17Mar2021 (Wednesday) night she took a pill for her cholesterol and had felt the acid build in her system about nine o clock, maybe 10, and she had to sit up to sleep. She asked if the Pfizer vaccine causes acid reflux to flare up more. On 18Mar2021 (Thursday), When she woke morning, she had a bunion on her right foot got inflamed, and when she looked at it, it was sore, and her foot was swollen in her big toe area and was inflamed. She had lots of pain. She felt that it was not due to her cholesterol medicine, but it occurred after she took the vaccine. She has always had the bunion but never had a flare up of redness, swelling, and soreness. Her pain level was a 10. Her uric acid was a 6. She did not know if it was still with the vaccine or not, she has had the bunion but never the swelling, redness, or inflammation. She stated that the acid problem she has had in the past but not like this. The patient indicated to a nurse that three days later she developed gout on 18Mar2021. The problems with the bunion started on 18Mar2021 (Thursday) morning. The patient visited Physician Office just for the bunion. The pain got worse on 19Mar2021 (Friday). She started the prednisone on 19Mar2021 (Friday) for the inflammation and it was a pack. She finished the prednisone by an unspecified date. As she gradually took the prednisone the swelling was gone. She thought it was still tender, there is some soreness but the swelling and redness, were gone. The bunion was still there. She supposed to see a podiatrist. She was going to the orthopedic doctor to see what caused the shooting pain in her left foot. It Was not always like that. Maybe had a tiny bit of pain, but the vaccine may have aggravated it more. She Went to an orthopedic who took X-rays. Had arthritis in her big toes and a spur that is on the right foot, which was little bit more painful. She Had always had the spur but looks like the vaccine aggravated it more. She stated that her acid reflux was controlled after medicine, but it got worse after she took the vaccine. She Had arthritis in her big does and Looks like the vaccine aggravated it more. In left foot, she had some pain that is like shooting pain. Went to get it checked out and was asked how she reacted to the Pfizer vaccine and walking. The patient stated two other individuals who are medical personnel also developed gout. But did not know if those people reported it to Pfizer. No further details provided. Someone else stated when they got the vaccine, it aggravated the arthritis more. No further details provided. Patient asked If people have memory problems, does the Pfizer vaccine make the memory problems worse. She Received her second dose of vaccine on 05Apr2021. The events Bunion redness and Bunion swelling were resolved on an unspecified date in 2021. the outcome of other event Acid reflux was not resolved and the outcome of other events was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Blood pressure high (It started in her 30s); Diabetic (It started in her 30s or early 40s)

ID: 1482296
Sex: F
Age:
State: FL

Vax Date: 02/27/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle contracted; Shoulder muscle hurting; Back, legs and both arms hurt, pain all over; This is a spontaneous report from a contactable consumer, the patient. A 72-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the right arm on 06Feb2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6200) via unspecified route of administration in the right arm on 27Feb2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other medications the patient received within 2 weeks of vaccination. On 25Mar2021 at 01:00, the patient experienced muscles at the left shoulder were contracted and formed a mass and were still hurting. The muscles in the front of both legs were contracted and hurt. The patients back hurt and both arms with pain all over. The patient had not tested positive for COVID-19 since having the vaccine and had nasal swab test (COVID-19 test) on 20Mar2021, resulted negative. The adverse event resulted in emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcomes of events muscle contractions, shoulder pain, and general body pain were not resolved. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482297
Sex: F
Age:
State:

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe muscle ache; Fatigue; High fever (103); Chills; Restless leg; Joint pain; Persistent headache; Mild cough; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 03Mar2021 at 15:00 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 27Mar2021 at 23:00, the patient experienced severe muscle aches, fatigue, fever (103 units unspecified), chills, restless leg, joint pain, persistent headache and mild cough. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for muscle ache, fatigue, fever, chills, restless leg, joint pain, headache and cough. The clinical outcomes of the events muscle ache, fatigue, fever, chills, restless leg, joint pain, headache and cough were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482298
Sex: F
Age:
State: CO

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fever; Body aches; pounding horrible headache; Unable to sleep; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: FP6955) via an unspecified route of administration on 22Mar2021 at 11:30, (at the age of 44- years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, eczema, seasonal allergies. The patient was allergic to Brazil nuts. The concomitant medication included ibuprofen (MANUFRATURER UNKNOWN) as needed, but not on the day of (unspecified). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 23.30 (12 hours after jab), the patient experienced chills alternating with fever, body aches, pounding horrible headache, unable to sleep (waking every hour) which lasted until 36 hours after jab. The patient did not receive any treatment for reported events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of chills, fever, headache, body aches and unable to sleep was resolved on 24Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds: IBUPREN

Current Illness:

ID: 1482299
Sex: F
Age:
State: WI

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: was 56-year-old at the time of vaccination), via an unspecified route of administration in arm left on 23Mar2021 at 09:41 as single dose for COVID-19 immunisation. Medical history included tooth infection and allergies to foods (she has allergies but she does not know, she does have some allergies to foods that would cause her throat to act up like that, but she avoids them at all costs). Vaccination facility type was hospital. There was no history of previous immunization with the Pfizer vaccine considered as suspect and no additional vaccines administered. The patient did not receive prior vaccinations within 4 weeks. The patient stated that she had the first vaccine on 23Mar2021 at 09:41 and she went to her local hospital in town and sat there for approximately 15 minutes after throat started feeling tight but there were a number of people in there, so it was warm in the room, and she had her mask on, so she thought her throat was just dry, since she was excited about getting the vaccine and that's why she did not say anything when the vaccine administration staff asked if the caller was ok, she thought she felt perfectly fine. She felt that in her throat literally 10-15 minutes and it progressively kept getting worse for 2.5 hours and she kept drinking ice water to cool her throat and took lozenges and went outside for some fresh air, it was cold outside and then she went home. She stated that it did not get to a point where she had to go back to the hospital, but it was very noticeable that her throat was swelling and she felt like she had a tumbleweed in her throat. The feeling lasted for two and a half hours, then it started dissipating but she did not feel normal until the next day. She could breathe but she just had a constriction in her throat for two and a half hours and then it started getting a little better where she could tell there was some relief. She kept moving her arm around so the vaccine could spread, but now she was concerned about getting the second one because of the experience with her throat. Her general practitioner told her to take five Benadryl 30 minutes before the vaccine and to stay an hour at the facility. She took one Benadryl on Wednesday after which knocked her out so there was no way she could take that, she would be in a drug coma if she took 5 Benadryl. No further details on the one Benadryl that knocked her out, were provided by the caller. The events did not require a visit to emergency room or physician office. The outcomes of the events throat tightness, throat swelling was recovered on 23May2021 and was unknown for the rest of the events. Follow-up attempts are completed. No further information is expected.

Other Meds: AMOXICILLIN

Current Illness:

ID: 1482300
Sex: F
Age:
State: MN

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme migraine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration as a single dose on 23Mar2021 at 14:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to sulfa and onions. The concomitant medications included buspirone hydrochloride (BUSPAR) and quetiapine (MANUFACTURER UNKNOWN) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination patient was not diagnosed with COVID-19. The patient has not tested for COVID-19 since vaccination. On 23Mar2021 at 15:30, the patient experienced extreme migraine since injection. The patient did not receive any treatment for reported event. The clinical outcome of migraine was not resolved at the time of this report. No follow-up attempts are needed. No further information expected.

Other Meds: BUSPAR; QUETIAPINE

Current Illness:

ID: 1482301
Sex: F
Age:
State: NY

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: been very thirsty; headache; left arm is very sore like if had been punched several times; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 3248), via an unspecified route of administration in the left arm on 24Mar2021 at 15:15 (at the age of 35-years old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248), via an unspecified route of administration in the left arm on 02Mar2021 (at the age of 35-years old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 at 15:30, after receiving the vaccine, the patient had a headache shortly afterwards that lasted a few hours. Her left arm was very sore like if had been punched several times. The patient had been very thirsty. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events headache, left arm is very sore like if had been punched several times and been very thirsty. The clinical outcomes of the events headache, left arm is very sore like if had been punched several times and been very thirsty were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482302
Sex: F
Age:
State: IL

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flulike symptoms (chills, body aches,slight fever, headache); Left arm/hand lymphedema (mastectomy area); Joint pain; flare of arthritis in hips, knees, ankles and feet; water retention/puffy face,; swollen lymph nodes in chest; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207/59267-1000-1) via an unspecified route of administration in the right arm on 22Mar2021 at 15:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included heart arrhythmia, breast cancer survivor, arthritis, mastectomy, autoimmune disease of blood and thyroid and severe sepsis survivor. The patient was allergic to tramadol (MANUFACTURER UNKNOWN), moxifloxacin (MANUFACTURER UNKNOWN) and hydrocodone (MANUFACTURER UNKNOWN). Concomitant medications included dronedarone hydrochloride (MULTAQ), levothyroxine sodium (SYNTHROID), metoprolol (MANUFACTURER UNKNOWN) and various supplements (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not tested with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 19:00, the patient had flulike symptoms (chills, body aches, slight fever, headache), lymphedema left arm/hand (mastectomy area), followed by joint pain, flare of arthritis (in hips, knees, ankles, feet), water retention/puffy face, swollen lymph nodes in chest and heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were taken for the adverse events included paracetamol (TYLENOL) and ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of the events flulike symptoms (chills, body aches, slight fever, headache), lymphedema left arm/hand (mastectomy area), joint pain, flare of arthritis (in hips, knees, ankles, feet), water retention/puffy face, swollen lymph nodes in chest and heart palpitations were recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHYROID; METOPROLOL; MULTAQ

Current Illness:

ID: 1482303
Sex: F
Age:
State: NC

Vax Date: 03/19/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Body aches; Fever 102.1; headache; felt fatigued; This is a spontaneous report from a non-contactable consumer, the patient . A 27-years old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207) via an unspecified route of administration in the left arm on 19Mar2021 at 16:45 (at the age of 27-years-old) as a single for COVID-19 immunisation. The patient medical history included gastritis due to H. Pylori. The concomitant medications included Famotidine (UNKNOWN MANUFACTURER),ethinylestradiol, ferrous fumarate, norethisterone acetate (LOESTRIN FE), bifidobacterium infantis (ALIGN), and Iron (UNKNOWN MANUFACTURER); all from unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 23Mar2021 at 08:30, the patient experienced headache and felt fatigued throughout the morning and about 16:00, the headache became unbearable and began to have chills and body aches and ended up having a 102.1 fever. The patient underwent lab tests and procedures, which included COVID test(nasal swab) on 24Mar2021 and resulted negative. Therapeutic measures were taken as a result of the events and included treatment herself Tylenol and woke up the next morning fever free and slight body aches which only lasted for a few more hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body aches, chills, fatigue, unbearable headache and fever was recovered on unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds: FAMOTIDINE; ALIGN; IRON; LOESTRIN FE

Current Illness:

ID: 1482304
Sex: F
Age:
State:

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fever; Headache; Muscle pain; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 69-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown) via an unspecified route of administration in the right arm on 03Mar2021 (at the age of 69-year-old) at 09:45 and second dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown) via an unspecified route of administration in the right arm on 24Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, high blood pressure (BP) The patient was allergic to penicillin and sulfonamide (Sulfa). Concomitant medications received within 2 weeks of the vaccination included unspecified daily prescription medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not tested positive for COVID-19. On 03Mar2021, after the first dose of vaccination, the patient experienced chills, fever, nausea, headache, muscle pain and joint pain. No therapeutic measures were taken for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events such as Chills, fever, nausea, headache, muscle pain and joint pain were recovered with lasting effects at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482305
Sex: F
Age:
State: NC

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Large lump under the right arm.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 20Mar2021 at 12:00 (at the age of 51-years-old) as a single dose, for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on an unspecified date at 11:30, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 at 16:00, the patient experienced large lump under the right arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the event. The clinical outcome of large lump under the right arm was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1482306
Sex: F
Age:
State:

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Achiness; Nausea; This is a spontaneous report received from a non contactable consumer, the patient. A 36-years-old non-pregnant female patient received BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 24Mar2021 at 13:00(at the age of 36 years) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not take any concomitant medications. The Patient previously took Penicillin for unknown indication and experienced an allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the Patient had not tested for COVID-19. On 25Mar2021 at 04:00, the patient experienced achiness and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the achiness and nausea was recovering. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482307
Sex: F
Age:
State: CA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Thumping sensation in eye, behind calf, abdomen, arm; Nosebleed; Thumping sensation in eye, behind calf, abdomen, arm; Thumping sensation in eye, behind calf, abdomen, arm; Thumping sensation in eye, behind calf, abdomen, arm; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unknown route of administration in left arm on an unknown date in Mar2021 at 12:30 (at the age of 62-year-old), as single dose for COVID-19 immunisation. Medical history included hypertension and asthma. The patient was allergic to prednisone. Concomitant medications included unspecified blood pressure medication, iron pill and multi-vitamin. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On an unknown date in Mar2021 at 00:30, the patient experienced nosebleed and thumping sensation in eye, behind calf, abdomen and arm. The patient had not received treatment for the reported events. The events had resulted in the visit to the doctor or other healthcare professional office/clinic visit. The clinical outcome of the events nosebleed and thumping sensation in eye, behind calf, abdomen and arm was recovering at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1482308
Sex: M
Age:
State: CA

Vax Date: 03/21/2021
Onset Date: 03/21/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red blisters rashes on the left side of the my body, right below my chest; Sharp pain at my left rib.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unknown route of administration in the left arm on 21Mar2021 at 10:30 (at the age of 52-year-old) as first single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. No known allergies reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medication included benazepril (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), aspirin (BAYER) and paracetamol (TYLENOL); all taken for unknown indication within two weeks of vaccination. On 21Mar2021 at 23:00, the patient experienced red blisters rashes on the left side of the body, right below the chest, and also experienced sharp pain at the left rib. The patient did not receive any treatment for the events. The clinical outcome of red blisters rashes on the left side of the body, right below the chest and sharp pain at the left rib was not recovered at the time of this report. No follow-up attempts possible. No further information expected.

Other Meds: BENAZEPRIL; SIMVASTATIN; Aspirin; TYLENOL

Current Illness:

ID: 1482309
Sex: F
Age:
State: WA

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen wrists; swollen hands; swollen knees; red hands; severe generalized reaction of significant swelling at all extremities and face; Upset stomach; loose stool; eye burning sensation; skin peeling in both hands; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 10Mar2021 at 14:45 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient had known allergies to some food (beans, pistachios, lactose intolerant), chemicals (in respirators, formol, latex etc), environmental, (dust, pollen, some trees) and medicine (tetracycline). Concomitant medications included claritine (MANUFACTURER UNKNOWN),vitamin C (MANUFACTURER UNKNOWN) and d3 (MANUFACTURER UNKNOWN) since an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient experienced red hands, severe generalized reaction of significant swelling at all extremities and face, upset stomach, loose stool, eye burning sensation and skin peeling in both hands on 10Mar2021 at 14:45. The patient experienced swollen wrists, hands and knees after 19 days after the first vaccination on an unknown date. The patient received treatment for the reported events included claritin and benadryl. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events red hands, severe generalized reaction of significant swelling at all extremities and face, upset stomach, loose stool, eye burning sensation, skin peeling in both hands, swollen wrists, hands and knees were not recovered at the time of this report. No follow up attempts are needed. No further information is expected

Other Meds: CLARITINE

Current Illness:

ID: 1482310
Sex: F
Age:
State: MI

Vax Date: 03/04/2021
Onset Date: 03/07/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Extreme nausea; Fever; Body aches; This is a spontaneous report from a contactable other health care professional, the patient. A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration in the left arm on 04Mar2021 at 18:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included PCOS (polycystic ovary syndrome). Concomitant medications included norethisterone acetate, ethinylestradioal and ferrous fumarate(HAILEY FE 1.5/30), spironolactone (MANUFACTURER UNKNOWN) and valacyclovir (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The Patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. The Patient had not tested for COVID-19 since the vaccination. On 07Mar2021 at 13:00, the patient experienced fatigue, extreme nausea, fever and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fatigue, extreme nausea, fever and body aches was recovered on unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds: HAILEY FE 1.5/30; SPIRONOLACTONE; Valacyclovir

Current Illness:

ID: 1482311
Sex: M
Age:
State: PA

Vax Date: 03/13/2021
Onset Date: 03/15/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: head pain on the right near ear and on top of head; This is a spontaneous report received from a contactable consumer, the patient. A 66-year-old elderly male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534), via unspecified route of administration in the right arm on 13Mar2021 at 18:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. No medical history was reported. The patient was allergic to eggs. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any medication within two weeks of COVID vaccine. On 15Mar2021 at 18:00, 48 hours after the first shot piercing the patient experienced head pain on the right near ear and on top of head which was sore to touch. The patient did not receive any treatment for the adverse event. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event headache was not recovered at the time of report. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1482312
Sex: F
Age:
State:

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lymph node swollen in arm pit; Legs red swollen and heated.; Legs red swollen and heated.; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 23Mar2021 at 13:30 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy and COVID-19. Concomitant medication included escitalopram oxalate (LEXAPRO) from unknown date for unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 12:00, the patient experienced lymph node swollen in arm pit, legs red swollen and heated. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen lymph nodes, swelling of legs and redness legs was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LEXAPRO

Current Illness:

ID: 1482313
Sex: M
Age:
State: CA

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Loss of taste and smell.; Severe headache.; Loss of taste and smell.; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not have allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6200 59267-1000) via an unspecified route of administration in the left arm on 02Mar2021 at 11.00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 24Mar2021 at 06.00, the patient experienced loss of taste and smell and severe headache. The patient did not receive any treatment for the reported events. Adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events loss of taste and smell and severe headache was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482314
Sex: F
Age:
State: CO

Vax Date: 03/01/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: unexpected therapeutic benefit; This is a spontaneous report from contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734), via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 11:45 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as allergic asthma, hypothyroidism, post-nasal drip, sneezing, and cough expectorating phlegm. The patient had drug allergies to sulfonamide drugs, fluconazole, montelukast, spriva and allergies to wines, melon and sulfites. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had received medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient experienced unexpected therapeutic benefit on 29Mar2021 at 12:45. It was reported that the event was a happy and unintended one, she believed. she had cough-variant allergic asthma and take inhalers for it daily, including bronco-dilators. The patient coughed a lot even with the inhalers was on a five-month hiatus from her allergy injections and off antihistamines while awaiting a skin test, so the patient coughing had been particularly severe. Within an hour of receiving her first COVID vaccine, her allergy symptoms (post-nasal drip, sneezing, and severe asthma cough expectorating phlegm) were completely gone. It was the weirdest thing but she was thrilled. The clinical outcome of event unexpected therapeutic benefit was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482315
Sex: F
Age:
State: CA

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; Chills; Extreme Fatigue; Body feels hot inside; Flushed Face; Dull ache on injection site; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 70-year-old female (non-pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6199, Pfizer NTEC), via an unspecified route of administration in right arm on 10Mar2021 1at 0:15 (at the of 70-year-old) as dose 1, single for covid-19 immunization. Medical history included chronic fatigue syndrome, fibromyalgia, type 2 diabetes, asthma and very sensitive to most medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other medication in 2 weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Patient experienced, nausea, chills, extreme fatigue, body feels hot inside, flushed face, dull ache on injection site on 10Mar2021 and ongoing for 19 days now. The adverse events resulted in physician office visit and emergency room visit. The patient did not receive any treatment. The clinical outcome for events was not recovered. Follow-Up (15Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482316
Sex: F
Age:
State: CO

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route in the left arm on 24Mar2021 at 10:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications with two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248), via an unspecified route in the left arm on 03Mar2021 at 14:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021 at 22:30, the patient had body aches and chills starting about 12 hours after dose and this lasted through the night. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was treated with ibuprofen (MANUFACTURER UNKNOWN) for the events body aches and chills. The clinical outcomes of the events body aches and chills were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482317
Sex: F
Age:
State: IN

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; Fatigue; Chills; Diarrhoea; 6lb weight loss within 24 hours; Constant burping; Bloating; Food taste bland; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8732) via an unspecified route of administration in the left arm on 28Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient had allergies to lisinopril and losartan. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) and liraglutide (SAXENDA) weight loss injection. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 29Mar2021 at 18:30, the patient experienced nausea, fatigue, chills, diarrhea for at least 24 hours, 6lb weight loss within 24 hours, loss of appetite, food taste bland that normally the patient find good, constant burping and bloating. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic treatment was taken for the reported events. The clinical outcome of the events diarrhea recovered on 30Mar2021. The clinical outcome of the events nausea, fatigue, chills, diarrhea, 6lb weight loss within 24 hours, loss of appetite, food taste bland that normally find good, constant burping and bloating were not resolved at the time of this report. No follow-up attempts are needed. No further information expected.

Other Meds: SAXENDA

Current Illness:

ID: 1482318
Sex: M
Age:
State: MD

Vax Date: 03/21/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash spots arms, legs, feet and itchy; Rash spots arms, legs, feet and itchy; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in right arm on 21Mar2021 at 13:30 (at the age of 47-years old) as a single dose for COVID-19 immunisation. Medical history included lactose/ gluten intolerance and known allergy with penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medications within two weeks of vaccination. On 22Mar2021, the patient experienced rash spots on arms, legs, feet and itchy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events rash spots on arms, legs, feet and itchy was not resolved at the time of this report. No follow-up attempts are needed Information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482319
Sex: F
Age:
State: CT

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness/faintness; Cold sweat; Tingling in left arm; Fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old non pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via unspecified route of administration in the left arm on 24Mar2021 at 16:30 (at the age of 51-years-old) as single dose for COVID-19 immunisation. Medical history included eosinophilic esophagitis. The patient did not had allergies to medications, food, or other product. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX) of 40 mg and ibuprofen (ADVIL) received on unspecified dates for unknown indications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 16:45, the patient experienced sudden onset of dizziness/faintness and cold sweat approximately 15 min after receiving shot, while waiting in monitoring area, tingling in left arm and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for adverse events. The clinical outcome of dizziness/faintness, cold sweat, tingling in left arm and fatigue were recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: Protonix; Advil

Current Illness:

ID: 1482320
Sex: F
Age:
State: KY

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left armpit hurts; feels like a golfball size knot; This is a spontaneous report from a contactable other health care professional, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had allergy to sulfa drugs. Concomitant medication included sertraline (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 07:00, the patient experienced left armpit hurts and felt like a golf ball size knot. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events armpit hurts and felt like a golf ball size knot were not recovered at the time of this report. Information about lot/batch number cannot be obtained; No follow-up attempts are needed;

Other Meds: Sertralin

Current Illness:

ID: 1482321
Sex: F
Age:
State: NJ

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle aches next day after injection 2; Tinnitus lasting 4 hours began 1 hour after injection; Washed out feeling; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included elevated blood pressure. The patient had known allergies to medications, food, or other products. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the left arm on 05Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 13:30, the patient experienced tinnitus lasted 4 hours began 1 hour after the vaccination and muscle aches next day after injection 2. The patient had washed out feeling lasted day one and day two after the second injection. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tinnitus was resolved on 26Mar2021, washed out was resolved on 27Mar2021 and muscle ache was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482322
Sex: M
Age:
State: PA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Minor rash on left arm between wrist and elbow.Rash went away in that area but moved to elbow area, but much smaller area.; This is a spontaneous report from a contactable other health care professional, the patient. A 73-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 00:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergies from an unknown date. The patient had known allergies to medications, food, or other products which are unspecified. Concomitant medication included LOTS for an unknown indication from an unknown date taken within 2 weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. one day after the vaccination on 26Mar2021 at 00:00, the patient experienced minor rash on left arm between wrist and elbow, rash went away in that area but moved to elbow area, but much smaller area. The patient did not receive any treatment for the events. The clinical outcome of the event rash on left arm between wrist and elbow was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482323
Sex: F
Age:
State: NC

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue lasting 4 days and counting, headache, nausea,; headache; nausea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch no: FR8730) via unspecified route of administration in the left arm on 26Mar2021 at 10:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine headaches. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), erenumab (AIMOVIG), simvastatin (MANUFACTURER UNKNOWN) and mirabegron (MYRBETRIQ); all from unspecified dates for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch no: EN6206) via unspecified route of administration in the left arm on an unspecified date in Mar2021 at 12:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 06:00, the patient experienced fatigue that lasted 4 days and counting, headache and nausea. No therapeutic measures were taken for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, headache and nausea were recovered with sequalae. No follow-up attempts needed. No further information expected.

Other Meds: CITALOPRAM; AIMOVIG; SIMVASTATIN; MYRBETRIQ

Current Illness:

ID: 1482324
Sex: F
Age:
State: CA

Vax Date: 03/21/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flared up on the day 6-7 after the vaccination. It used to be local in two joints and now I am flared up all over my body; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Mar2021 at 10:30 (at 36 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included rheumatoid arthritis (RA) from unspecified date. The patient had no known allergies. Concomitant medications included methotrexate, prednisone, and etanercept (ENBREL); all from unspecified date for unspecified indication. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient reported her RA that had been pretty much in remission flared up on the day 6-7 after the vaccination. It used to be local in two joints and now she was flared up all over her body. She did not see any other reason apart from the vaccination. Start date of the adverse event was 27Mar2021. The event resulted in physician office visit. No treatment received for the event. Outcome of the event was not recovered. Information about batch/lot number has been requested.

Other Meds: METHOTREXATE; PREDNISONE; ENBREL

Current Illness:

ID: 1482325
Sex: F
Age:
State: NY

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; Neck pain; Painful head; Fever/ lowest 99.9, highest 101.4; extremely cold extremities; lethargic; This is a spontaneous report from contactable consumer, the patient. A 63 years old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration on left arm on 24Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included Hypertension, hypothyroid, obesity and collagenous colitis. Concomitant medication included famotidine (MANUFACTURER UNKNOWN), torsemide (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), methylcellulose (CITRUCEL), vitamins nos, minerals nos (CENTRUM) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration on left arm on 03Mar2021 at 13:45 (at the age of 63 years old) as a single dose for COVID-19 immunisation, also received MACROBID and was allergic to it. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021 at 09:00, patient experienced body aches including neck and head more painful to hold up head, fever at (lowest 99.9 range and highest 101.4 range), extremely cold extremities in hands and feet this lasted for 36 hours. lethargic lasted for 3 days and total of 5 days. The lab data on 25Mar2021 included body temperature and ranges between lowest 99.9 and highest 101.4. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken for the adverse events. The clinical outcome for the events cold extremities recovered on 26Mar2021 at 21:00, while the event of lethargy was recovered on 27Mar2021, while the events body aches, neck pain, head pain, fever, cold extremities in hands and feet was recovered on 30Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: FAMOTIDINE; TORSEMIDE; VALSARTAN; CITRUCEL; Centrum

Current Illness:

ID: 1482326
Sex: F
Age:
State: FL

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: At 10:30 that evening I had a couple of hives.; At 10:30 that evening I had a red stomach,; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 15:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies. The patient was allergic to penicillin. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and diphenhydramine hydrochloride (BENADRYL) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not tested with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 22:30, the patient experienced hives and red stomach. Therapeutic measures were taken as a result of hives and red stomach and included treatment with BENADRYL. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of hives and red stomach were recovered at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BENADRYL; Zyrtec

Current Illness:

ID: 1482327
Sex: F
Age:
State: OH

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomiting; This is a spontaneous report received from a contactable consumer, the patient. A 20-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications of the patient included fluoxetine hydrochloride (PROZAC), cyproheptadine (MANUFACTURER UNKNOWN) and birth control from an unknown date and for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient experienced vomiting. The patient did not receive any treatment for the reported event. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vomiting was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC; CYPROHEPTADINE

Current Illness:

ID: 1482328
Sex: F
Age:
State: ME

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme fatigue; Low grade flu symptoms; Vertigo; Dizziness; Vision effected; This is a spontaneous report from a contactable consumer, patient. A 54-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included hydrochlorothiazide (HTCZ) (MANUFACTURER UNKNOWN), bimatoprost (LATISSE), magnesium (MANUFACTURER UNKNOWN), commiphora mukul, piper longum, terminalia bellirica, terminalia chebula (TRIPHALA GUGGULU), melissa officinalis extract and origanum vulgare extract (MELATON). The patients had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021 at 15:00 after 4.5 hours post shot, the patient experienced extreme fatigue, then low-grade flu symptoms. The patient felt like she was coming down with something. It was reported as two days out, the patient experienced vertigo, dizziness and vision was affected. The events vertigo and dizziness had continued till 30Mar2021 (third day). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the reported events. The clinical outcome of the events fatigue, low-grade symptoms, vertigo, dizziness and vision affected were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROCHLOROTHIAZIDE; LATISSE; TRIPHALA GUGGULU; MAGNESIUM; Melaton

Current Illness:

ID: 1482329
Sex: M
Age:
State: NY

Vax Date: 03/01/2021
Onset Date: 03/13/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8733) via an unspecified route of administration in the left arm in Mar2021 at 13:30 (at the age of 51-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6206) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 51-years-old) as single doses for COVID-19 immunisation. Medical history included asthma. The patient did not have any allergies to food, medications, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 09:00, about week after the first dose, the patient had cramping and a lot pain up and down the legs. For example, when the patient sat, it was hard to stand and legs were almost petrified. When the patient walked it was sore and painful. This lasted for about 4 to 5 days. After the second dose, the morning after it started again and was actually worst than previous time. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events cramp legs, leg pain, difficulty in standing and difficulty in walking. The clinical outcomes of the events cramp legs, leg pain, difficulty in standing and difficulty in walking were unknown at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482330
Sex: M
Age:
State: MD

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Increased appetite; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 28Mar2021 at 14:15 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The facility where the patient received the vaccine was at a pharmacy or drug store. On 28Mar2021 at 15:00, the patient experienced increased appetite for 12 hours. The patient did not receive any treatment for the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event increased appetite was recovered on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482331
Sex: F
Age:
State: GA

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mouth and tongue started tingling; Mouth and tongue started tingling; Mouth and tongue numbness; Throat numbness; Mouth and tongue numbness; Throat also got very itchy; Slightly difficult to swallow; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in arm left on 29Mar2021 at 11:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy- allergic to medications with sulfur and fruit allergy (Mango was the only food she have ever had a reaction to). Concomitant medications included ZYRTEC, NASACORT, turmeric/curcumin, vitamin D3, vitamin B12, vitamin C and zinc. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with Covid-19 prior to vaccination. Since the vaccination, the patient was not tested for COVID-19. On 29Mar2021 at 11:30, within 30 minutes after the shot, the patients mouth and tongue started tingling and feeling numb at the same time. It felt like there was swelling but the patient did not see swelling when she had a look in the mirror at the back of her throat and she was unsure whether the numbness might made it feel swollen. The patient described that her mouth, tongue and throat felt like she had just received a numbing injection at the dentist or gargled with lidocaine. The patient also got very itchy throat and it was slightly difficult to swallow. The patient stated that she took 50 mg of Benadryl upon arriving home after the vaccination. The numbness and tingling lasted about 7 hours. The patient clarified that she did not see a doctor as her breathing was fine and the next morning, her throat was still itchy but numbness and tingling were gone. The patient had taken Benadryl as a therapeutic measure for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tingling mouth and tongue, numb mouth, numbness in tongue and numbness throat were recovered on 30Mar2021. The clinical outcome of itchy throat and swallowing difficult was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Zyrtec; NASACORT; Turmeric; VITAMIN D3; Vitamin b12; Vitamin C; ZINC

Current Illness: Fruit allergy (Mango is the only food I've ever had a reaction to); Sulfonamide allergy (Allergic to medications with sulfur)

ID: 1482332
Sex: F
Age:
State: OH

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; Nausea; Loss of appetite; Taste altered; Headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er26213) via an unspecified route of administration in the arm left on 19Mar2021 at 14:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. The patient did not receive any concomitant medications. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 18:00, the patient experienced fever, chills, nausea, loss of appetite, taste altered and headache. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, loss of appetite, taste altered and headache was recovered in Mar2021 (unspecified date). No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482333
Sex: F
Age:
State: WV

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very swollen injection site; red at injection site; hot and sore at injection site; Rash on upper body; vaccination site itching; Upper body itching; Sick to stomach; bad headache; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration, in the left arm on 29Mar2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and depression. Allergies to medications, food or other products included peanut, peanut by products, thimerosal, penicillin and amoxicillin allergy. Concomitant medications received within 2 weeks of vaccination included lamotrigine (LAMICTAL), venlafaxine hydrochloride (EFFEXOR), calcium (MANUFRATURER UNKNOWN) and vitamin D (MANUFRATURER UNKNOWN) all were from unknown date and for unspecified indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not get any other vaccine within 4 weeks of COVID-19 vaccine. On 29Mar2021, at 20:00 the patient experienced very swollen, red, hot and soreness at injection site. Rash on upper body that has started on last night and hasn't get better. The patient also reported itches on upper body and around injection site, and stomach discomfort and bad headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the adverse events was reported as no. The clinical outcome of the events very swollen, red, hot and sore at injection site, rash and itches on upper body, itches around injection site, stomach discomfort and headache were not recovered. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LAMICTAL; EFFEXOR; CALCIUM; VITAMIN D NOS

Current Illness:

ID: 1482334
Sex: F
Age:
State: WI

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy body welts; welts; tight throat; This is a spontaneous report from a contactable healthcare professional, nurse. A 29-years-old-non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207) via intramuscular route of administration in the left arm on 09Mar2021 at 14:45 (at the age of 29-years-old) as a single dose for Covid-19 immunisation. The patient medical history and Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 09Mar2021 at 18:45, within 4 hours of first dose, the patient experienced tight throat. On the next day, 10Mar2021, the patient experienced itchy body welts. It was reported that the patient cancelled her 2nd dose after experiencing these events. No therapeutic measures were received as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events tight throat, itchy body and welts were recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482335
Sex: F
Age:
State: OH

Vax Date: 03/25/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lump under left armpit the size of a golf ball; Tender lump under left armpit.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number ER2613) via an unspecified route of administration in the left arm on 25Mar2021, at 15:00 (at the age 62-years-old), as a single dose for COVID-19 immunisation. Medical history included breast cancer and atrial fibrillation(A-Fib). Allergies to medications included avelox, celebrex, lortab/vicaden, oxycodone/percocet. Concomitant medications received within 2 weeks of vaccination included apixaban (ELIQUIS), propafenone (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), and atorvastatin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN6203) via an unspecified route of administration in the left arm on 04Mar2021, at 15:30 as a single dose for COVID-19 immunisation. The patient did not get any other vaccine within 4 weeks of COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 29Mar2021, the patient underwent COVID-19 molecular test and the result was negative. On 27Mar2021 at 04:00, the patient experienced event of lump under left armpit the size of a golf ball and event of tender lump under left armpit. The events did not result in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events was reported as no. The clinical outcome of event lump under left armpit the size of a golf ball and event tender lump under left armpit was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ELIQUIS; PROPAFENONE; PANTOPRAZOLE; ATORVASTATIN

Current Illness:

ID: 1482336
Sex: F
Age:
State: MO

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 62-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 26Mar2021 at 15:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, type 2 diabetes mellitus, psoriatic arthritis and possibly sulfonamide allergy. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On 27Mar2021 at 08:00, the patient experienced swelling, lump, redness and pain where the vaccine was administered. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling, lump, redness and pain were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482337
Sex: F
Age:
State: MA

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; headache; brain fog; sore throat; middle of the night stomach cramps; vomiting; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EIL8732), via an unspecified route of administration in the left arm on 28Mar2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to codeine. The concomitant medications included atomoxetine hydrochloride (STRATTERA), ethinylestradiol, etonogestrel (NUVARING), amlodipine (MANUFACTURER UNKNOWN) for unknown indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 29Mar2021 at 23:45, the patient experienced sore arm, headache, brain fog, sore throat, middle of the night stomach cramps, vomiting, diarrhoea. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events sore arm, headache, brain fog, sore throat, middle of the night stomach cramps, vomiting and diarrhoea were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: STRATTERA; NUVARING; AMLODIPINE

Current Illness:

ID: 1482338
Sex: M
Age:
State: NC

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; fever; numbness; This is a spontaneous report from a contactable consumer, the patient. A 24-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Er8733) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6206) via an unspecified route of administration in the left arm on 04Mar2021 at 09:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was not reported if the patient was allergic to medications, food, or other products. The patient experienced fever, numbness, dizziness on 30Mar2021 at 06:15. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of fever, dizziness, numbness was unknown at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482339
Sex: M
Age:
State: NJ

Vax Date: 03/15/2021
Onset Date: 03/18/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Achy left arm; fingers (left) feel tingly and almost numb; finger almost numb; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: PFIZEREP7534); via an unspecified route of administration in the left arm on 15Mar2021 at 08:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications within two weeks prior to the COVID vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 at 07:00, the patient experienced achy left arm very painful to sit, to lay in bed or drive (pain felt like it hit his funny bone). The patient experienced fingers (left) tingly and almost numb. The arm pain started 3 days after the first dose. The adverse event resulted in doctor or other healthcare professional office/clinic visit/ emergency visit/ department or urgent care. Therapeutic measures were taken as a result of pain in arm, tingling and numbness and included ibuprofen, cyclobenzaprine and naproxen. The clinical outcome of the events pain in arm, tingling and numbness were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482340
Sex: F
Age:
State: MO

Vax Date: 03/27/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left arm bruised; Left arm swollen; Left underarm swollen; Left underarm painful; Left side to waist swollen; Left side to waist painful; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 27Mar2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto disease, COVID-19, anxiety due to COVID illness and COVID-19 anosmia. Allergies to medications included ampicillin and penicillin. Concomitant medications received within 2 weeks of vaccination included levothyroxine (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and sambucus nigra (ELDERBERRY). Prior to vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 29Mar2021, the patient experienced events of bruise in left arm, swollen left arm, swollen left underarm, painful left underarm, left sided swelling to waist, left sided pain to waist. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the adverse events was reported as no. The clinical outcome of events bruise in left arm, swollen left arm, swollen left underarm, painful left underarm, left sided swelling to waist, left sided pain to waist was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; CITALOPRAM; MAGNESIUM; Elderberry

Current Illness:

ID: 1482341
Sex: F
Age:
State: FL

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache until current (no relief),; occasional random pulsatingsensation in left bicep muscle; Usual injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via unspecified route of administration in the left arm on 28Mar2021 at 10:30 (at the age of 45-years-old) as a single dose for Covid-19 immunisation. Medical history included rheumatoid arthritis. The patient did not have allergies to medication, food or other products. Concomitant medication included multivitamins (MANUFACTURER UNKNOWN), vitamin D nos (VITAMIN D), Isotretinoin (MANUFACTURER UNKNOWN) and fexofenadine hydrochloride (ALLEGRA). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 03:00, the patient experienced headache (continuing), occasional random pulsating sensation in left bicep muscle (abnormal sensation of limbs) and usual injection site soreness. The patient did not receive any treatment for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the event headache was not resolved. The clinical outcome of the events abnormal sensation of limbs and vaccination site pain was unknown. No follow-up attempts are needed. No further information expected.

Other Meds: Vitamin d; ISOTRETINOIN; ALLEGRA

Current Illness:

Total 2021 VAERS Injuries: 563,404

Page last modified: 03 October 2021 5:28pm